100 Years of Immunotherapy

Posted: 30th July 2013 | Posted by AdminMR

Aims of the Monaco Charter: (1) to present the current evidence on the efficacy and safety of allergen-specific immunotherapy (SIT) and to address the reasons for its underuse in clinical practice; (2) to develop strategies to increase the awareness about the benefits and the hazards of SIT in allergic patients, lay public and healthcare professionals not trained in allergy, and (3) to make SIT accessible and affordable to eligible patients.

Vol. 160, No. 4, 2013 

Free Access

View or print article as PDF (137 KB)

Position Paper

100 Years of Immunotherapy: The Monaco Charter
Under the High Patronage of His Serene Highness Prince Albert II of Monaco
G. Walter Canonica^a, Carlos E. Baena-Cagnani^d, Enrico Compalati^a, Barbara Bohle^c, Sergio Bonini^b, Jean Bousquet^e, Linda Cox^f, Antje H. Fink-Wagner^g, Sandra González Díaz^h, Lars Jacobsenⁱ, Giovanni Passalacqua^a, Ruby Pawankar^j, Stefan Vieths^l, Osman Yusuf^k, Torsten Zuberbier^m